RXST RxSight, Inc.

4.650USD-2.31%Mkt Cap: 193.41M $P/E: —

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It …

Key Statistics

Company
Market Cap193.41M USD
Enterprise Value-4.81M USD
Revenue (TTM)127.58M USD
Gross Profit103.01M USD
Net Income (TTM)-38.94M USD
Revenue/Share3.09 USD
Last Price4.650 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees461
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.67
PEG—
EV/EBITDA0.09
EV/Revenue-0.04
P/S1.52
P/B0.73
EPS (TTM)-1.14
EPS (Forward)-0.70
52W Range
4.4802% of range13.22
52W High13.22 USD
52W Low4.480 USD
Profitability
Gross Margin76.60%
Oper. Margin-40.81%
EBITDA Margin-40.42%
Profit Margin-28.96%
ROE-14.13%
ROA-12.49%
Growth
Revenue Growth0.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.51M USD
CapEx (TTM)3.83M USD
FCF Margin-5.28%
FCF Yield-3.48%
Net Debt-198.22M USD
Net Debt/EBITDA3.84
Balance Sheet
Debt/Equity0.04
Current Ratio4.07
Quick Ratio3.57
Book Value/Sh6.33 USD
Cash/Share5.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.1 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.569 USD
Upside (mean)+62.8%
Target Range5.500 USD – 11.00 USD
5.500+62.8% to mean11.00
# Analysts8
Ownership
Shares Out.41.59M
Float33.71M
Insiders6.57%
Institutions104.52%
Short Interest
Short Ratio5.0d
Short % Float10.09%
Short % Out.9.56%
Shares Short3.98M
Short (prev mo.)4.26M
Technical
SMA 505.984 (-22.3%)
SMA 2006.925 (-32.9%)
Beta1.14
S&P 52W Chg16.45%
Avg Vol (30d)797.20K
Avg Vol (10d)792.92K
Technical Indicators
RSI (14)32.2
MACD-0.4093
MACD Signal-0.3567
MACD Hist.-0.0526
BB Upper6.803 USD
BB Middle5.348 USD
BB Lower3.892 USD
BB Width54.43%
ATR (14)0.2957 USD
Vol Ratio (20d)0.80x